Autism and Schizophrenia: Intestinal Disorders

Nutritional Neuroscience

Volumn 3, Issue 1, 2000, Pages 57-72

  Cade, Robert ^a   Privette, Malcolm ^a   Fregly, Melvin ^a   Rowland, Neil ^a   Sun, Zhongjie ^a   Zele, Virginia ^a   Wagemaker, Herbert ^a,b   Edelstein, Charlotte ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Autism; Casein; Diet; Gliadorphin; Gluten; Schizophrenia; Casomorphin

Indexed keywords

BOVINAE;

EID: 0347997552     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1028415X.2000.11747303     Document Type: Article

References (48)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., Washington, D.C.
2. Asperger, H. (1961) Dir Psychopathologie des coeliaki kranken kindes. Annual Paediatric 197: 346-351.
3. Bohlen, P., Castillo, F., Ling, R. and Guillemin, R. (1980) Purification of peptides: An efficient procedure for the separation of peptides from amino acids and salts. International Journal of Peptide Protein Research 16: 306-310.
4. Cade, R., Wagemaker, H., Privette, R.M., Fregly, M., Rogers, J. and Orlando, J. (1990) The effect of dialysis and diet on schizophrenia. Psychiatry: A World Perspective 1: 494-500.
5. Carpenter Jr., W.T., Sadler, J.H., Light, P.D., Hanlon, T.E., Kurland, A.A., Penna, M.W., Reed, W.P., Wilkinson, E.H. and Bartko, J.J. (1983) The therapeutic efficacy of hemodialysis in schizophrenia. New England Journal of Medicine 308: 669-675.
6. Coleman, M. (1976) Calcium studies and their relationship to coeliac disease in autistic patients. In: The Autistic Syndromes, Coleman, M. (Ed.), pp. 197-205. North Holland Publishing Corp., Amsterdam, The Netherlands.
7. D'Eufemia, R., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E. and Giardini, O. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatrics 85: 1076-1079.
8. Dohan, F.C. (1966) Cereals and Schizophrenia. Data and hypothesis. Acta Psychiatry Scandinavia 42: 125-152.
9. Dohan, F.C. and Graberger, J.C. (1973) Relapsed schizophrenics: Earlier discharge from the hospital after cereal-free, milk-free diet. American Journal of Psychiatry 130: 685-686.
10. Dohan, F.C. (1983) More on coeliac disease as a model for schizophrenia. Biological Psychiatry 18: 561-564.
11. Gardner, M.L.G. (1994) Absorption of intact proteins and peptides. In: Physiology of the Gastrointestinal Tract, 3rd edn., L.R. Johnson (Ed.) pp. 1795-1820. Raven Press, New York, N.Y.
12. Goodwin, M.S., Cowen, M.A. and Goodwin, T.C. (1971) Malabsorption and cerebral dysfunction: A multivariate and comparative study of autistic children. Journal of Autism and Childhood Schizophrenia 1: 48-62.
13. Hagman, B. (1990) The Gluten-Free Gourmet. Living Well without Wheat. Henry Holt & Co., New York, New York.
14. Hedlund, J.L. and Vieweg, B.W. (1980) The Brief Psychiatric Rating Scale (BPRS): A comprehensive review. Journal of Operational Psychiatry 11: 48-65.
15. Hole, K., Bergslien, H. and Jorgensen, H.A. (1979) A Peptide containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptake. Neuroscience 4: 1883-1893.
16. Hole, K., Lingjaerde, O., Morkrid, L., Boler, J.B., Saelid, G., Diderichsen, J., Ruud, E. and Reichelt, K.L. (1988) Attention deficit disorders: A study of peptide-containing urinary complexes. Journal of Developmental Behavioral Pediatrics. 9: 205-212.
17. Hui, K.-S., Hui, M., Banay-Schwartzl, M., DeGusman, T., Ling, N. and Lajhta, A. (1983) Encephalin-containing polypeptides are potent inhibitors of encephlin degradation. Peptides 4: 639-646.
18. Husby, S., Jensenius, J.D. and Svehag, S.E. (1985) Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scandinavian Journal of Immunology 22: 83-92.
19. Jorgensen, H.D. and Cappelen, C. (1992) Naloxone-induced reduction of schizophrenic symptoms: A case report. Acta Psychiatric Scandinavia 63: 102.
20. Kidder, B. (1988) The Milk-Free Kitchen, Living Well without Dairy Products. Henry Holt & Co., New York, New York.
21. Knivsberg, A.M., Wiig, K., Lind, G., Nodland, M. and Reichelt, K.L. (1990) Dietary intervention in autistic syndromes. Brain Dysfunction 3: 315-327.
22. Knivsberg, A.M., Reichelt, K.L., Nodland, M. and Hoien, T. (1995) Autistic syndromes and diet. A four year follow-up study of 15 subjects. Scandinavian Journal of Educational Research 39: 223-236.
23. Lucarellie, S., Fredimn, T., Zingam, A., Ferizzi, Fl., Giardoni, O., Quinterica, F., Barbato, M., D'Eufimia, P. and Corti, R. (1993) Food allergies and infantile autism. Pan Minerva Medicine 37: 34-141.
24. Marchi, A.C., Tuvo, F. and Mardio, S. (1974) Child autism and gluten intolerance. Acta Paediatric Scandinavia 63: 102.
25. Olesson, I., Steffenberg, S. and Gillberg, C. (1988) Epilepsy in Autism and Autistic-like conditions. Archives of Neurology 48: 666-668.
26. Panksepp, J., Herma, B., Vilbeg, T., Bishop, P. and DeEskinase, F.G. (1980) Endogenous opioids and social behavior. Neuroscience Behavioral Review 4: 473-487.
27. Panksepp, J. (1978) A neurochemical theory of autism. Trends in Neurosciences 2: 174-177.
28. Pratesi, R., Gandolfi, L., Friedman, H., Farage, L., de Castro, C.A. and Catassi, C. (1998) Serum IgA antibodies from patients with coeliac disease react strongly with human brain blood-vessel structures. Scandinavian Journal of Gastroenterology August; 33(8): 817-821.
29. Reichelt, K.L., Hole, K., Hamberger, A., Saelid, G., Edminson, P.D., Braestrup, C.B., Lingjaerde, O., Ledaal, P. and Orbeck, H. (1981) Biologically active peptide-containing fractions in schizophrenia and childhood autism. Advances in Biochemical Psychopharmacology 28: 627-643.
30. Reichelt, K.L., Saelid, G., Lindback, J. and Orbeck, H. (1986) Childhood autism: A complex disorder. Biological Psychiatry 21: 1279-1290.
31. Reichelt, K.L., Ekram, J. and Scott, H. (1990) Gluten, milk protein and autism: Dietary intervention effects on behavior and peptide secretion. Journal of Applied Nutrition 42: 1-11.
32. Reichelt, K.L. and Landmark, J. (1995) Specific IgA antibody increases in schizophrenia. Journal of Biological Psychiatry 37: 410-413.
33. Reichelt, K.L. (1996) Dialysis in schizophrenia: Successful only in a subtype? Schizophrenia Research May; 19(2-3): 223-224.
34. Reichelt, K.L., Seim, A.R. and Reichelt, W.H. (1996) Could schizophrenia be reasonably explained by Dohan's hypothesis on genetic interaction with a dietary peptide overload? Progress Neuropharmacology and Biological Psychiatry 10: 1-32.
35. Reichelt, W., Ek, J., Samsrud, M. and Reichelt, K.L. (1998) Peptide excretion in celiac disease. Journal of Pediatric Gastroenterology and Nutrition 26: 305-309.
36. Rodriguez, Trav, A.L., Barreiro Marin, P., Galvez, Borrero, I.M., del Olmo Romero-Nieva, F. and Diaz Alvarez, A. (1994) Association between autism and schizophrenia. Journal of Nervous and Mental Disease, August; 182(8): 478-479.
37. Rui, I. and Goldstein, A. (1982) Opioid and other peptides as inhibitors of leumorphin (Dynorphin 13-29) converting activity. Peptides 7: 87-90.
38. Scott, H., Rognum, T.D., Midtuedt, T.J. and Brandtzaeg, P. (1985) Age related changes of serum antibodies to dietary and colonic antigens measured by enzyme-linked immunosorbent assay. Acta Pathological Microbiological Scandinavia (c) 93: 65-70.
39. Shattock, P., Kennedy, A., Rosell, F. and Berney, T. (1990) Role of neuropeptides in autism and their relationships with classical neurotransmitters. Brain Dysfunction 3: 328-345.
40. Shattock, P. and Lowdon, G. (1991) Proteins and peptidases. Part 2. Implications for the education and care of people with autism. Brain Dysfunction 4: 323-334.
41. Shutte, J.G. (1977) Everything You Always Wanted to Know About Elementary Statistics but were Afraid to Ask, Prentice-Hall, Inc. Englewood Cliffs, New Jersey.
42. Stuart, C.A., Twiselton, R., Nicholas, M. and Hide, D.W. (1984) Passage of cow's milk protein in breast milk. Clinical Allergy 14: 533-535.
43. Sun, Z., Cade, J.R., Fregly, M.J. and Privette, R.M. (1999a) β-Casomorphin induces fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Autism 3(1): 67-83.
44. Sun, Z. and Cade, R. (1999b) A peptide found in schizophrenia and autism causes behavioral changes in rats. Autism 3(1): 85-95.
45. Trygstad, O.E., Reichelt, K.L. and Foss, I. (1980) Patterns of peptides and protein associated peptide complexes in psychiatric disorders. British Journal of Psychiatry 136: 59-72.
46. Volkmar, F.R. and Nelson, D.S. (1995) Seizure disorders in autism. Journal of American Academy of Childhood and Adolescent Psychiatry 29: 127-129.
47. Wagemaker, H. and Cade, J.R. (1977) The use of hemodialysis in schizophrenia. American Journal of Psychiatry 134: 684-685.
48. Whitely, P., Rodgers, J., Savory, D. and Shattock, P. (1997) Preliminary findings from the implementation of a gluten free diet in children with autism and associated spectrum disorders. In: Living and Learning with Autism Paul Shattock and Gillian Linfoot (Eds.), pp. 182-197. The Autism Research Unit, Sunderland Univ., UK.